Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

5.79USD
27 Mar 2015
Change (% chg)

$0.08 (+1.40%)
Prev Close
$5.71
Open
$5.74
Day's High
$5.97
Day's Low
$5.61
Volume
199,354
Avg. Vol
225,538
52-wk High
$7.83
52-wk Low
$3.15

PGNX.OQ

Chart for PGNX.OQ

About

Progenics Pharmaceuticals, Inc. is a medicine developing company. The Company is engaged in developing medicines for oncology. Its focus for Progenics is targeted therapeutics and imaging agents. The Company’s clinical development efforts center on late-stage oncology assets. Its principal clinical-stage product candidates in... (more)

Overall

Beta: 1.68
Market Cap(Mil.): $403.22
Shares Outstanding(Mil.): 69.64
Dividend: --
Yield (%): --

Financials

  PGNX.OQ Industry Sector
P/E (TTM): 443.68 40.31 40.78
EPS (TTM): 0.01 -- --
ROI: 3.36 16.86 16.19
ROE: 4.33 17.40 17.04
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks